FDA.reportPublic FDA data

Eye Allergy Itch Relief - TARGET CORPORATION

Manufacturer
TARGET CORPORATION
Effective date
2026-02-03
Label type
Human OTC Drug Label
Version
1
Source
daily-update
Hydrated at
2026-08-18 02:02:16

Label at a glance#

ProductEye Allergy Itch Relief
Active ingredientOLOPATADINE HYDROCHLORIDE
Label structure15 sections

Dosage and administration

adults and children 2 years of age and older: put 1 drop in the affected eye(s) once daily do not use more than 1 drop in each eye per day if using other ophthalmic products while using this product, wait at least 5 minutes between each product replace cap after each use children under 2 years of age: consult a doctor

Label contents#

Full prescribing information#

SPL PRODUCT DATA ELEMENTS SECTION

SPL UNCLASSIFIED SECTION

ACTIVE INGREDIENT

OTC - ACTIVE INGREDIENT SECTION

Olopatadine (0.7%) (equivalent to olopatadine hydrochloride 0.776%)

PURPOSE

OTC - PURPOSE SECTION

Antihistamine


USE

INDICATIONS & USAGE SECTION

temporarily relieves itchy eyes due to pollen, ragweed, grass, animal hair and dander

WARNINGS

WARNINGS SECTION

For external use only

DO NOT USE

OTC - DO NOT USE SECTION

• if solution changes color or becomes cloudy 
• if you are sensitive to any ingredient in this product
• to treat contact lens related irritation

WHEN USING THIS PRODUCT

OTC - WHEN USING SECTION

• do not touch tip of container to any surface to avoid contamination
• remove contact lenses before use
• wait at least 10 minutes before reinserting contact lenses after use
• do not wear a contact lens if your eye is red


STOP USE AND ASK DOCTOR IF

OTC - STOP USE SECTION

you experience:  

  • eye pain
  • changes in vision
  • increased redness of the eye
  • itching worsens or lasts for more than 72 hours

KEEP OUT OF REACH OF CHILDREN

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away(1-800-222-1222).

DIRECTIONS

DOSAGE & ADMINISTRATION SECTION

  • adults and children 2 years of age and older:
  • put 1 drop in the affected eye(s) once daily
  • do not use more than 1 drop in each eye per day
  • if using other ophthalmic products while using this product, wait at least 5 minutes between each product
  • replace cap after each use
  • children under 2 years of age: consult a doctor

OTHER INFORMATION

OTHER SAFETY INFORMATION

• only for use in the eye
• store between 2° to 25°C (36° to 77°F)

INACTIVE INGREDIENTS

INACTIVE INGREDIENT SECTION

benzalkonium chloride 0.015% (preservative), boric acid, hydrochloric acid/sodium hydroxide (to adjust pH), hydroxypropyl gamma-cyclodextrin, hypromellose, mannitol, polyethylene glycol 400, povidone and purified water.

QUESTIONS?

OTC - QUESTIONS SECTION

call toll-free weekdays 8 AM to 8 PM EST at 1-888-375-3784

SPL UNCLASSIFIED SECTION

Distributed by:

Target Corporation

Minneapolis,

MN 55403

Made in India

*This product is not manufactured or distributed by Alcon Laboratories Inc., distributor of Pataday® Once Daily Relief Extra Strength. Pataday® is a registered trademark of Novartis AG.

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Carton Label:

NDC 82442-027-25


Extra Strength

Eye Allergy Itch Relief

Olopatadine Hydrochloride
Ophthalmic Solution USP, 0.7%
Antihistamine

ONCE DAILY RELIEF

Full 24HR

Works in Minutes

Sterile

2.5 mL (0.085 fl oz)

 

Compare to Pataday Once Daily Relief Extra Strength active ingredient*

Tamper Evident: Packaged with Tamper-Evident bottle cap. Do Not Use if breakable ring is separated or missing.

For Ages 2 and Older

30 DAY SUPPLY

PlaceholderPlaceholder




Bottle Label:

Extra Strength

Eye Allergy Itch Relief

Olopatadine Hydrochloride
Ophthalmic Solution USP, 0.7%
Antihistamine
ONCE DAILY RELIEF

Sterile 
2.5 mL (0.085 fl oz)

Placeholder
Placeholder

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 13 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
82442-02782442-027-25, 82442-027-50

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 11 matching rows.

Name, UNII, Kind table
NameUNIIKind
OLOPATADINE HYDROCHLORIDE2XG66W44KFACTIM
BENZALKONIUM CHLORIDEF5UM2KM3W7IACT
BORIC ACIDR57ZHV85D4IACT
HYDROCHLORIC ACIDQTT17582CBIACT
HYDROXYPROPYL .GAMMA.-CYCLODEXTRINP6BYU725IUIACT
HYPROMELLOSE 2910 (4000 MPA.S)RN3152OP35IACT
MANNITOL3OWL53L36AIACT
POLYETHYLENE GLYCOL 400B697894SGQIACT
POVIDONE K30U725QWY32XIACT
SODIUM HYDROXIDE55X04QC32IIACT
WATER059QF0KO0RIACT

Source Document#

Source XML

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A213514-001OLOPATADINE HYDROCHLORIDEOLOPATADINE HYDROCHLORIDEEQ 0.7% BASESOLUTION/DROPS / OPHTHALMIC2026-01-06

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A213514-001OLOPATADINE HYDROCHLORIDEEQ 0.7% BASESOLUTION/DROPS / OPHTHALMIC2026-01-0684e616aacf4f…
2026-08-18 06:07:402026-07A213514-001OLOPATADINE HYDROCHLORIDEEQ 0.7% BASESOLUTION/DROPS / OPHTHALMIC2026-01-06caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A213514-001OLOPATADINE HYDROCHLORIDEEQ 0.7% BASESOLUTION/DROPS / OPHTHALMIC2026-01-06011fe1cb6892…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A213514-001OLOPATADINE HYDROCHLORIDEEQ 0.7% BASESOLUTION/DROPS / OPHTHALMIC2026-01-06a50c72e98297…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Eye Allergy Itch ReliefOLOPATADINE HYDROCHLORIDETARGET CORPORATIONaa112cbd-35c0-a723-48cc-21137332b2c32026-02-03WarningsExact identifier
ndc (package): 82442-027-25
ndc (package): 82442-027-50
ndc (product): 82442-027
ndc11 (package): 82442002750
ndc11 (package): 82442002725
spl id: fc28766c-0cc5-996f-4332-7913d9b1c62d
spl set id: aa112cbd-35c0-a723-48cc-21137332b2c3

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.